The safety and efficacy of second-line single docetaxel (75 mg/m²) therapy in advanced non-small cell lung cancer patients who were previously treated with platinum-based chemotherapy.

Abstract

PURPOSE When used in the second-line setting, single-agent chemotherapy has produced response rates of more than 10% or median survival times greater than 4 months. We studied the safety and efficacy of using second-line single docetaxel (75 mg/m²) for advanced NSCLC patients who were previously treated with platinum-based chemotherapy in Korea. MATERIALS… (More)
DOI: 10.4143/crt.2005.37.6.339

Topics

Cite this paper

@article{Shim2005TheSA, title={The safety and efficacy of second-line single docetaxel (75 mg/m²) therapy in advanced non-small cell lung cancer patients who were previously treated with platinum-based chemotherapy.}, author={Byoung Yong Shim and Chi Hong Kim and So Hyang Song and Meyung Im Ahn and Eun Jung Hong and Sung Whan Kim and Suzy S Kim and Min Seop Jo and Deog Gon Cho and Kyu Do Cho and Jinyoung Anny Yoo and Hoon-Kyo Kim}, journal={Cancer research and treatment : official journal of Korean Cancer Association}, year={2005}, volume={37 6}, pages={339-43} }